首页> 外文期刊>P & T: a peer-reviewed journal for formulary management >Prevalence of Delirium and Coma In Mechanically Ventilated Patients Sedated With Dexmedetomidine or Propofol
【24h】

Prevalence of Delirium and Coma In Mechanically Ventilated Patients Sedated With Dexmedetomidine or Propofol

机译:机械通气的右美托咪定或丙泊酚镇静患者的Deli妄和昏迷患病率

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To assess the prevalence of delirium and coma in mechanically ventilated patients sedated with dexmedetomidine or propofol alone; to evaluate the hospital length of stay for both treatment groups; and to evaluate the level of sedation, adverse effects, and hospital outcomes.Methods: Medical records were reviewed retrospectively for patients who were admitted to the medical or surgical intensive care units (IGUs) in a 591-bed teaching hospital and who received either dexmedetomidine or propofol alone for 24 hours or more for sedation.Results: A total of 111 patients were included in the study, with 56 patients in the dexmedetomidine group and 55 patients in the propofol group. Results of the analysis showed that the propofol group had a higher prevalence of coma (43.6% versus 12.5%; P < 0.001). Dexmedetomidine patients had a longer median hospital length of stay of 23.5 days (interquartile range [IQR], 11.5-39.5 days) versus 15.0 days (IQR, 7.0-24.0 days; P = 0.01). The rates-of delirium were similar in both groups, with 16% in dexmedetomidine-treated patients versus 20% in propofol-treated patients (P = 0.63).
机译:目的:评估仅使用右美托咪定或丙泊酚镇静的机械通气患者的of妄和昏迷患病率;评估两个治疗组的住院时间;方法:回顾性地回顾了在591张病床的教学医院就诊的内科或外科重症监护病房(IGU)并接受右美托咪定的患者的病历结果:共纳入111例患者,右美托咪定组56例,丙泊酚组55例。分析结果表明,丙泊酚组的昏迷患病率更高(43.6%对12.5%; P <0.001)。右美托咪定患者的中位住院时间更长,为23.5天(四分位间距[IQR],11.5-39.5天),而15.0天(IQR,7.0-24.0天; P = 0.01)。两组的del妄发生率相似,右美托咪定组患者为16%,丙泊酚组患者为20%(P = 0.63)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号